This study aimed to investigate the causal relationships between circulating lipid metabolites and the risk of estrogen receptor–positive (ER+) and ER-negative (ER−) breast cancer using a bidirectional Mendelian randomization (MR) approach. The gene discussed is ESR1; the disease is breast cancer.